You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADCC

Showing 1 - 25 of 205
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and

Not yet recruiting
  • HER2+ Advanced Breast Cancer
  • Other Solid Tumors
  • ADCC-R-Epo-R T-cells + Trastuzumab
  • +2 more
  • (no location specified)
Aug 31, 2023

Adenoid Cystic Carcinoma of the Head and Neck Trial (OBT076, Balstilimab)

Not yet recruiting
  • Adenoid Cystic Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

HER2-positive Breast Cancer, Operable Breast Cancer Trial in France (Trastuzumab + Paclitaxel, Pegfilgrastim)

Recruiting
  • HER2-positive Breast Cancer
  • Operable Breast Cancer
  • Avignon, France
  • +8 more
Jan 9, 2023

Colorectal Cancer, ADCC Trial in Napoli (Folfiri/Cetuximab)

Recruiting
  • Colorectal Cancer
  • ADCC
  • Napoli, Italy
    Istituto Nazionale dei Tumori,
Sep 1, 2021

Hepatocellular Carcinoma Trial in Guangzhou (ADCC & TACE, TACE)

Completed
  • Hepatocellular Carcinoma
  • ADCC & TACE
  • TACE
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-sen University
Oct 28, 2020

Family Members, Dependence Trial in Salamanca (Intervention)

Completed
  • Family Members
  • Dependence
  • Intervention
  • Salamanca, Spain
    Fundacion INFOSALUD
Nov 13, 2022

Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)

Recruiting
  • Locally Advanced Breast Cancer
  • Chemotherapy Effect
  • inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
  • Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 28, 2023

Penpulimab in Maintenance Therapy in Lymphoma

Not yet recruiting
  • Lymphoma
  • (no location specified)
Dec 25, 2022

Breast Cancer Trial in Guangzhou (Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus AI)

Recruiting
  • Breast Cancer
  • Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus AI
  • Guangzhou, Guangdong, China
    Shusen Wang
Jul 1, 2021

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • BNT321 Dose Level 1
  • +3 more
  • (no location specified)
Sep 29, 2023

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line

Recruiting
  • Breast Neoplasms
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Mar 16, 2023

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency Trial in Minneapolis (FT538, Vorinostat)

Not yet recruiting
  • HIV-1-infection
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 31, 2023

Subclass of Donor-specific Antibody asRisk Factor of Antibody

Active, not recruiting
  • Antibody-mediated Rejection
    • Montpellier, Hérault, France
      CHU Lapeyronie
    Jan 18, 2023

    Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)

    Recruiting
    • Rheumatoid Arthritis
    • +8 more
    • COVID-19 vaccine
    • Montréal, Quebec, Canada
    • +1 more
    Jan 13, 2023

    SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)

    Not yet recruiting
    • SARS-CoV2 Infection
    • Coronavirus Infection
    • Hamilton, Ontario, Canada
      McMaster University
    Jun 29, 2022

    Breast Cancer, Breast Tumors, Breast Cancer Female Trial in Germany (Ontruzant, Chemotherapy, Pertuzumab)

    Recruiting
    • Breast Cancer
    • +3 more
    • Heidelberg, Baden-Wuerttemberg, Germany
    • +10 more
    Aug 30, 2021

    Breast Cancer Trial in Guangzhou (Inetetamab, Pyrotinib, Capecitabine)

    Recruiting
    • Breast Cancer
    • Guangzhou, Guangdong, China
      Sun Yat Sen Memorial Hospital，Sun Yat sen University
    Dec 18, 2020

    Advanced or Metastatic Solid Tumors Trial in Tianjin (JS012, JS012 combine with chemo)

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • JS012
    • JS012 combine with chemotherapy
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    May 19, 2022

    Clear-Cell Renal Carcinoma Trial run by the NCI (rhIL-15, Avelumab)

    Terminated
    Has Results
    • Clear-Cell Renal Carcinoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 27, 2022

    Lymphoma, Primary Effusion Trial run by the National Cancer Institute (NCI) (Daratumumab SC)

    Not yet recruiting
    • Lymphoma, Primary Effusion
    • Daratumumab SC
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 23, 2023

    Ebola Disease, Marburg Disease Trial in Atlanta (Ad26 Zaire Ebola Vaccine, MVA Multi-Filo Ebola Vaccine)

    Completed
    • Ebola Disease
    • Marburg Disease
    • Ad26 Zaire Ebola Vaccine
    • MVA Multi-Filo Ebola Vaccine
    • Atlanta, Georgia
      Emory Children's Center - Pediatric Infectious Diseases
    Feb 18, 2021

    HIV Trial in Tygerberg Hills (HIVIS DNA/MVA-CMDR, HIVIS DNA + Cervarix and MVA-CMDR, Cervarix)

    Recruiting
    • HIV Infections
    • HIVIS DNA/MVA-CMDR
    • +2 more
    • Tygerberg Hills, Cape Town, South Africa
      Stellenbosch University
    Apr 20, 2022

    Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum

    Not yet recruiting
    • Neuromyelitis Optica Spectrum Disorders
    • (no location specified)
    Sep 29, 2023